{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T23:40:54Z","timestamp":1746142854984},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,22]]},"DOI":"10.7759\/cureus.58778","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T01:53:56Z","timestamp":1713837236000},"source":"Crossref","is-referenced-by-count":1,"title":["Ibuprofen Would Be the First-Line Nonsteroidal Anti-inflammatory Drug for Polymyalgia Rheumatica: A Case Series of Five Patients"],"prefix":"10.7759","author":[{"given":"Shigeko","family":"Inokuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2022.0218","article-title":"Polymyalgia Rheumatica","volume":"119","author":"Colombo MG","year":"2022","unstructured":"Colombo MG, Wetzel AJ, Haumann H, Dally S, Kirtschig G, Joos S. Polymyalgia Rheumatica. Dtsch Arztebl Int. 2022, 119:411-7. 10.3238\/arztebl.m2022.0218","journal-title":"Dtsch Arztebl Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta B","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H, et al.. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012, 71:484-92. 10.1136\/annrheumdis-2011-200329","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05819-z","article-title":"Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis","volume":"41","author":"Floris A","year":"2022","unstructured":"Floris A, Piga M, Chessa E, et al.. Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis. Clin Rheumatol. 2022, 41:19-31. 10.1007\/s10067-021-05819-z","journal-title":"Clin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213883","article-title":"Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study","volume":"77","author":"Partington RJ","year":"2018","unstructured":"Partington RJ, Muller S, Helliwell T, Mallen CD, Abdul Sultan A. Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study. Ann Rheum Dis. 2018, 77:1750-6. 10.1136\/annrheumdis-2018-213883","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/medsci7090092","article-title":"Incidence and prevalence of polymyalgia rheumatica (PMR): the importance of the epidemiological context. The Italian Case","volume":"7","author":"Manzo C","year":"2019","unstructured":"Manzo C. Incidence and prevalence of polymyalgia rheumatica (PMR): the importance of the epidemiological context. The Italian Case. Med Sci (Basel). 2019, 7:92. 10.3390\/medsci7090092","journal-title":"Med Sci (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.04.001","article-title":"Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015","volume":"47","author":"Crowson CS","year":"2017","unstructured":"Crowson CS, Matteson EL. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015. Semin Arthritis Rheum. 2017, 47:253-6. 10.1016\/j.semarthrit.2017.04.001","journal-title":"Semin Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.38.5.434","article-title":"An evaluation of criteria for polymyalgia rheumatica","volume":"38","author":"Bird HA","year":"1979","unstructured":"Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979, 38:434-9. 10.1136\/ard.38.5.434","journal-title":"Ann Rheum Dis"},{"key":"ref8","article-title":"Polymyalgia rheumatica and giant cell arteritis: rapid evidence review","volume":"106","author":"Raleigh MF","year":"2022","unstructured":"Raleigh MF, Stoddard J, Darrow HJ. Polymyalgia rheumatica and giant cell arteritis: rapid evidence review. Am Fam Physician. 2022, 106:420-6.","journal-title":"Am Fam Physician"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000100","article-title":"Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review","volume":"1","author":"Mackie SL","year":"2015","unstructured":"Mackie SL, Koduri G, Hill CL, et al.. Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review. RMD Open. 2015, 1:000100. 10.1136\/rmdopen-2015-000100","journal-title":"RMD Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303452","article-title":"Sarilumab for relapse of polymyalgia rheumatica during glucocorticoid taper","volume":"389","author":"Spiera RF","year":"2023","unstructured":"Spiera RF, Unizony S, Warrington KJ, et al.. Sarilumab for relapse of polymyalgia rheumatica during glucocorticoid taper. N Engl J Med. 2023, 389:1263-72. 10.1056\/NEJMoa2303452","journal-title":"N Engl J Med"},{"key":"ref11","article-title":"","author":"Rainsford K","year":"1999","unstructured":"Rainsford K. History and Development of Ibuprofen. CRC Press, London, UK; 1999."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-231619","article-title":"Meningitis due to non-steroidal anti-inflammatory drugs: an often-overlooked complication of a widely used medication","volume":"12","author":"Desgranges F","year":"2019","unstructured":"Desgranges F, Tebib N, Lamy O, Kritikos A. Meningitis due to non-steroidal anti-inflammatory drugs: an often-overlooked complication of a widely used medication. BMJ Case Rep. 2019, 12:231619. 10.1136\/bcr-2019-231619","journal-title":"BMJ Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.36.3.239","article-title":"Action of nonsteroidal, anti-inflammatory drugs on human and rat peripheral leucocyte migration in vitro","volume":"36","author":"Brown KA","year":"1977","unstructured":"Brown KA, Collins AJ. Action of nonsteroidal, anti-inflammatory drugs on human and rat peripheral leucocyte migration in vitro. Ann Rheum Dis. 1977, 36:239-43. 10.1136\/ard.36.3.239","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0406-y","article-title":"Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer","volume":"6","author":"Pennock ND","year":"2018","unstructured":"Pennock ND, Martinson HA, Guo Q, et al.. Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer. J Immunother Cancer. 2018, 6:98. 10.1186\/s40425-018-0406-y","journal-title":"J Immunother Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01574-17","article-title":"Antimicrobial activity of ibuprofen against cystic fibrosis-associated gram-negative pathogens","volume":"62","author":"Shah PN","year":"2018","unstructured":"Shah PN, Marshall-Batty KR, Smolen JA, et al.. Antimicrobial activity of ibuprofen against cystic fibrosis-associated gram-negative pathogens. Antimicrob Agents Chemother. 2018, 62:01574-17. 10.1128\/AAC.01574-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13867","article-title":"Ibuprofen and diclofenac treatments reduce proliferation of pancreatic acinar cells upon inflammatory injury and mitogenic stimulation","volume":"175","author":"Bombardo M","year":"2018","unstructured":"Bombardo M, Malagola E, Chen R, Rudnicka A, Graf R, Sonda S. Ibuprofen and diclofenac treatments reduce proliferation of pancreatic acinar cells upon inflammatory injury and mitogenic stimulation. Br J Pharmacol. 2018, 175:335-47. 10.1111\/bph.13867","journal-title":"Br J Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00363-w","article-title":"Ibuprofen and NSAID use in COVID-19 infected patients is not associated with worse outcomes: a prospective cohort study","volume":"10","author":"Esba LCA","year":"2021","unstructured":"Esba LCA, Alqahtani RA, Thomas A, Shamas N, Alswaidan L, Mardawi G. Ibuprofen and NSAID use in COVID-19 infected patients is not associated with worse outcomes: a prospective cohort study. Infect Dis Ther. 2021, 10:253-68. 10.1007\/s40121-020-00363-w","journal-title":"Infect Dis Ther"},{"key":"ref18","unstructured":"BRUFEN tablets. (2024). Accessed. January 3, 2024: https:\/\/www.info.pmda.go.jp\/go\/pack\/1149001D1160_1_11\/?view=frame&style=XML&lang=ja."},{"key":"ref19","unstructured":"Ibren. (2024). Accessed. January 3, 2024: https:\/\/www.info.pmda.go.jp\/go\/pack\/1149001D1160_1_11\/?view=frame&style=XML&lang=ja."},{"key":"ref20","unstructured":"Cases with a suspected adverse event (in Japanese). (2024). Accessed. January 3, 2024: https:\/\/www.pdr.net\/drug-summary\/Ibuprofen-Tablets-ibuprofen-2618."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/222148-ibuprofen-would-be-the-first-line-nonsteroidal-anti-inflammatory-drug-for-polymyalgia-rheumatica-a-case-series-of-five-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T01:54:03Z","timestamp":1713837243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/222148-ibuprofen-would-be-the-first-line-nonsteroidal-anti-inflammatory-drug-for-polymyalgia-rheumatica-a-case-series-of-five-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.58778","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,22]]}}}